^MTM services are additional to provision of a drug product and include a broad range of pharmacists' activities within the scope of pharmacy practice. ^An example of MTM includes creating a medication treatment plan. ^Another example is monitoring and evaluating a patient's response to therapy.
Approximately a dozen pharmaceutical manufacturers are using light-up, wireless-connected pill bottles to improve medication adherence.
A survey of new Rx, new generic, and new OTC products
Do North Carolina pharmacists REALLY want to work 14 hours straight? If so, that's some work ethic.
When it comes to medication adherence, calendar blister packs have it all over those old-fashioned vials.
The AACE and Takeda Pharmaceuticals North America Inc. have partnered to launch the Diabetes Navigator, a collection of type 2 diabetes information available online for patients and caregivers.
An FDA Drug Safety Communication sent to healthcare professionals states that Dasatinib (Sprycel, Bristol-Myers Squibb) may increase the risk of pulmonary arterial hypertension.
Researchers found saw palmetto extract did not reduce urinary tract symptoms in 369 men with benign prostatic hyperplasia, a study reported recently in JAMA.
FDA recently announced that the District Court for the Middle District of Florida entered a consent decree that prohibits Hill Dermaceuticals Inc., Hill Labs Inc., and certain individuals from introducing adulterated drugs into interstate commerce.
FDA has approved ipratropium bromide and albuterol (Combivent Respimat Inhalation Spray, Boehringer Ingelheim) for patients using a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator.
FDA has approved sitagliptin and simvastatin (Juvisync, MSD International GmbH Clonmel), a fixed-dose combination prescription medication that contains 2 previously approved medications in 1 tablet for use by adults who need both sitagliptin and simvastatin.
FDA has approved tadalafil (Cialis, Eli Lilly) for 3 indications: ED, the signs and symptoms of BPH, and ED and the signs and symptoms of BPH in men who have both conditions.
FDA is now requiring prescribing information for Reclast (zoledronic acid, Novartis) to include a warning against use of the drug by patients with renal dysfunction.
An interaction between warfarin and acetaminophen may result in significant elevations of international normalized ratio (INR), putting patients at increased risk for hemorrhagic complications.
Nonsteroidal anti-inflammatory drugs (NSAIDs) should be used with caution during pregnancy, as exposure may increase the risk of spontaneous abortion, reported a study published online September 6 in the Canadian Medical Association Journal.
People who carry more weight for a longer period of time are at a greater risk of developing type 2 diabetes, a new study has reported.
The National Community Pharmacists Association is joining forces with GeriMed to support long-term-care pharmacies.
SCRIPT Version 10.6, the standard for e-prescribing and related transactions that the National Council for Prescription Drug Programs has been recommending for several years, will be coming into use in upcoming months.
An FDA advisory panel voted 9-2 (with 1 abstention) to recommend approval for rivaroxaban (Xarelto, Johnson & Johnson and Bayer AG), an oral, once-daily anticoagulant as a treatment to prevent stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
Annual flu vaccines are the best way to protect children from life-threatening pneumonia, according to new guidelines from the Pediatric Infectious Diseases Society and the Infectious Disease Society of America.
This year?s annual meeting of the American College of Clinical Pharmacy taking place October 16 through October 19 in Pittsburgh, Pa., will offer several sessions in 3 different curricular tracks.
Pharmacists and other healthcare professionals have the opportunity to attend a clinical vaccinology course at the Grand Hyatt Atlanta in Atlanta, Ga., November 4 through November 6, 2011.
Only one-fifth of children in Ohio who are prescribed antidepressants complete the recommended mimimum six-month course of drugs to treat depression, a new study reported.
FDA has issued a Safety Announcement warning that serious allergic reactions have been reported with the use of the antipsychotic medication asenapine maleate (Saphris).
FDA has approved orphenadrine citrate injection, USP (Sagent Pharmaceuticals), a skeletal muscle relaxant as an adjunct to rest, physical therapy, and other measures to support relief from acute, painful musculoskeletal conditions.
